Arcutis Biotherapeutics, Inc.
ARQT
Clasificación en acciones
#3954
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Precio por acción
$32.83
Capitalización bursátil
$4.13B
Cambio (1 día)
2.93%
Cambio (1 año)
57.21%
País
US
Comercio Arcutis Biotherapeutics, Inc. (ARQT)
Categoría
Healthcare
Número de acciones en circulación de Arcutis Biotherapeutics, Inc. (ARQT)
Número de acciones en circulación al June 2026: 130.52M
Según los últimos informes financieros y el precio de las acciones de Arcutis Biotherapeutics, Inc., el número actual de acciones en circulación es 130.52M. Al final de December 2023, la empresa tenía 69.31M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Arcutis Biotherapeutics, Inc. (ARQT) desde 2017 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 130.52M | 7.91% |
| 2024 | 120.96M | 74.53% |
| 2023 | 69.31M | 25.94% |
| 2022 | 55.03M | 11.39% |
| 2021 | 49.41M | 38.52% |
| 2020 | 35.67M | -6.36% |
| 2019 | 38.09M | 5.11% |
| 2018 | 36.24M | 3,331.44% |
| 2017 | 1.06M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 94.53% |
US
|
|
| 396.00M | 203.40% |
US
|
|
| 478.91M | 266.92% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -52.36% |
NL
|
